Login / Signup

True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.

Robert L GottliebAndre C Kalil
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Keyphrases
  • coronavirus disease
  • sars cov
  • small molecule
  • high throughput
  • risk factors
  • respiratory syndrome coronavirus
  • single cell